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experimental challenge with 
bovine respiratory syncytial virus in 
dairy calves: bronchial lymph node 
transcriptome response
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Jeremy f. taylor  3 & Sinead M. Waters1
Bovine Respiratory Disease (BRD) is the leading cause of mortality in calves. the objective of this study 
was to examine the response of the host’s bronchial lymph node transcriptome to Bovine Respiratory 
Syncytial Virus (BRSV) in a controlled viral challenge. Holstein-friesian calves were either inoculated 
with virus (103.5 tciD50/ml × 15 ml) (n = 12) or mock challenged with phosphate buffered saline (n = 6). 
clinical signs were scored daily and blood was collected for haematology counts, until euthanasia at day 
7 post-challenge. RNA was extracted and sequenced (75 bp paired-end) from bronchial lymph nodes. 
Sequence reads were aligned to the UMD3.1 bovine reference genome and differential gene expression 
analysis was performed using edgeR. there was a clear separation between BRSV challenged and 
control calves based on gene expression changes, despite an observed mild clinical manifestation 
of the disease. Therefore, measuring host gene expression levels may be beneficial for the diagnosis 
of subclinical BRD. There were 934 differentially expressed genes (DEG) (p < 0.05, FDR <0.1, fold 
change >2) between the BRSV challenged and control calves. Over-represented gene ontology terms, 
pathways and molecular functions, among the DeG, were associated with immune responses. the 
top enriched pathways included interferon signaling, granzyme B signaling and pathogen pattern 
recognition receptors, which are responsible for the cytotoxic responses necessary to eliminate the 
virus.
Bovine Respiratory Disease (BRD) is the leading cause of morbidity and mortality in calves over one month of 
age in Ireland1–4 and internationally5–8. It is a multifactorial disease, involving infectious agents (both viral and 
bacterial), host factors, management practices, environmental stress factors and their interactions4,8–11. Viruses 
generally initiate BRD and the damage they cause to the respiratory tract predisposes the calves to a secondary 
infection caused by bacteria, many of which are normal flora of the bovine upper respiratory tract12.
Bovine Respiratory Syncytial Virus (BRSV) is one of the main viral infectious agents responsible for the 
onset of BRD13. BRSV is an enveloped, non-segmented, negative-stranded RNA virus and is a member of the 
Orthopneumovirus genus within the family Pneumoviridae14,15. The morbidity resulting from infection with BRSV 
is in the range of 60% to 80%, and mortality is reported to be 20%15. The disease resulting from infection with 
BRSV can vary from sub-clinical to severe manifestation of clinical signs including coughing, pyrexia, nasal dis-
charge, anorexia and respiratory distress15. Lung pathology resulting from BRSV infection is primarily due to the 
host inflammatory response, particularly the induction of pro-inflammatory cytokines (IL12B, IFNG, TNF, IL6, 
IL18, CXCL8, CCL5, CCL2, CCL3, IFNA1 and IFNB1) and the influx of leukocytes, particularly neutrophils13,15. 
Establishment and maintenance of BRSV infection is facilitated through the virus’ ability to interfere with the 
host’s interferon (anti-viral) response and to induce immunomodulation by shifting the adaptive immune 
response away from a cell mediated response towards a Th2 dominated response15,16.
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Despite the risk of BRD susceptibility being moderately heritable17, there is a paucity of literature describing 
the molecular immune response of the host to infection with agents of the bovine respiratory disease complex 
(BRDC), such as BRSV. Two RNA-Seq studies performed in crossbred Angus-Hereford beef calves that were 
artificially challenged with single pathogens of the BRDC at the University of California Davis have discovered 
multiple genes and pathways to be differentially expressed following a BRSV challenge in bronchial lymph node18 
and in multiple lymphoid and lung tissues19. However, no work has been carried out to date to examine the tran-
scriptional response to a BRSV challenge in artificially-reared Irish dairy bull calves. The aims of this study were: 
(1) to describe the clinical and haematological response to a BRSV challenge infection, (2) to elucidate the genes 
and pathways involved in the host’s bronchial lymph node transcriptome response to an experimental challenge 
with BRSV in Irish artificially-reared dairy calves, and (3) to compare the bronchial lymph node transcriptomic 
response of these dairy calves challenged with BRSV to that of the crossbred beef calves challenged with BRSV at 
the University of California Davis18. These differentially expressed genes (DEG), and in particular the genes which 
were commonly differentially expressed in both the present study and the US study18 may harbour variants which 
influence the host’s resistance to BRSV.
Materials and Methods
preparation of the BRSV inoculum. Foetal calf lung (FCL) primary cells were grown in T75 tissue culture 
flasks using G-MEM BHK-21 media (Gibco #21710-025) with 10% foetal calf serum. BRSV strain SVA 274/92 
cell lysate20 was removed from the −80 °C freezer and defrosted. A 1:7 dilution was prepared using G-MEM 
BHK-21 media containing 2% foetal calf serum. Growth media was removed and the virus stock (2 ml) was added 
to each flask of FCL cells and incubated at 37oC in 5% CO2 for 1 hour. The flasks were removed from the incubator 
and G-MEM BHK-21 media (18 ml) containing 2% foetal calf serum was added. The flasks were transferred to 
the incubator and incubated until the cytopathic effect was greater than 50%. Cell sheets were freeze-thawed to 
release intracellular virus, centrifuged at 500 g for 5 minutes at 4 °C to remove cellular debris, aliquoted and stored 
at −80 °C.
Animal model. All animal studies were carried out in accordance with the UK Animals (Scientific 
Procedures) Act 1986 and with the approval of the Agri-Food and Biosciences Institute Northern Ireland Ethical 
Review Committee.
Animals were selected from a population of 30 Holstein-Friesian bull calves (mean age ± s.d. = 120.7 ± 14.15 
days) and recruited into the study based on low BRSV specific maternally derived antibody (MDA) levels and 
negative BRSV PCR status two weeks prior to challenge. As the challenge and necropsy were staggered across 
three days, recruited animals were assigned to three groups (A, B and C) based on sire, age (A = 135 ± 14 days, 
B = 134 ± 16 days, C = 133 ± 22 days), weight (A = 154.7 ± 14.0 kg, B = 155.0 ± 14.00 kg, C = 155 ± 19.00 kg) and 
MDA levels (A = 11.9 ± 5.48 MDA, B = 11.8 ± 5.15 MDA, C = 11.3 ± 6.13 MDA). The study included two treat-
ments; calves were either challenged with BRSV (n = 12; groups B and C) or were mock challenged with sterile 
phosphate buffered saline (PBS) (n = 6; group A) (Control). The difference between treatment groups B and C 
was that they were housed in separate locations.
Animal accommodation. The calves entered and were acclimatised to their houses on day −7 relative to the 
challenge (Fig. 1). Two of the houses (housing groups A and B) were class 3 animal houses which were identical 
in layout (10.03 m × 5.01 m) while the third house was an older, separate house (6.65 m × 3.70 m). The floors were 
covered with sawdust and a calf restraining chute was contained within each of the calf houses.
Animal diet. Prior to the trial, from arrival to Agri-Food Biosciences Institute (AFBI) Stormont at 3 weeks 
of age, the calves were reared indoors and received 2 feeds per day of 2 litres of 23% protein, 23% fat, calf milk 
replacer (Thompsons high fat; Trouw Nutrition Limited), ad libitum silage and approximately 200 g of calf weaner 
nuts (Calf Pride Weaner Mix; John Thompson and Sons, Limited) to encourage them to start eating concentrates. 
They were weaned from the calf milk replacer at 8–10 weeks of age and subsequently fed ad libitum silage and 
approximately 1.5 kg of Calf Pride Rearing Nuts which was increased to 2 kg per day as the calves grew. For the 
duration of the trial, the calves were offered water and silage ad libitum and were fed 2 kg concentrates (17% crude 
protein, 4% crude oil, 9.5% crude fibre, 7.5% crude ash, 0.28% magnesium, 0.28% sodium) (Calf Pride Rearing 
Nuts; John Thompson and Sons, Limited).
Figure 1. The BRSV challenge timeline. The numbers within the timeline represent the number of days relative 
to the day of the challenge (day 0).
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Animal sampling. On days −1, 0, 6 and 7, relative to the challenge (day 0), a 9 ml K3 EDTA blood tube was 
collected, gently inverted several times and placed on ice (Fig. 1). Whole blood was analysed for haematological var-
iables (white blood cell count, neutrophil percentage, lymphocyte percentage, monocyte percentage and eosinophil 
percentage) on an ABAXIS H5 haematology analyser (ABRAXIS Model: H5 S/N: 364372) immediately following 
collection. Daily, from the challenge to the day of slaughter, clinical signs (nasal discharge, ocular discharge, general 
demeanour, size of mandibular lymph nodes, presence of a cough, respiratory rate, respiratory character, mouth 
breathing, dyspnoea, presence of an expiratory grunt and rectal temperature) were recorded and scored by a vet-
erinarian, who was blinded to the calves’ treatment status (BRSV challenged or control), (Fig. 1) using a modified 
version of the clinical scoring system described by Gershwin et al.21 (Supplementary Table S1). Using this scoring 
system, points were accrued for each abnormal clinical symptom and the total number of points corresponded with 
the severity of disease, such that higher clinical scores were associated with more severe BRD21.
On the day of the challenge, calves were either administered with 103.5 TCID50/ml × 15 ml of BRSV inoculum 
(BRSV challenged calves in groups B and C) or mock challenged with 10 ml PBS (control calves in group A) by 
aerosol inhalation.
Animals were restrained in a cattle crush and the head was further restrained to prevent movement during 
nebulisation. Animals were nebulised with BRSV strain SVA 274/9220 or PBS using the Omron NE-U780 nebu-
liser (OMRON Model: NE-U780-E S/N: 20151200182AF) fitted with a veterinary face mask (GaleMed Model: 
VM-2 Animal Mask size 5 22mmlD Ref: 5635 Lot: 151019). Airflow and nebulisation volume settings were set to 
the maximum. BRSV inoculum (20 ml) was placed into the chamber and nebulised over 15 minutes. The remain-
ing volume of inoculum was checked after 15 minutes and if less than 10 ml had been nebulised, nebulisation was 
continued for an additional 5–10 minutes.
On day 7 relative to the challenge, calves were euthanized by captive bolt. The lungs were scored for lesions by 
a veterinarian using an AFBI standard lung scoring system which assigns the percentages of lesions present on the 
total lung area and on component parts of the lungs (Supplementary Fig. S1).
The workspace and implements were thoroughly cleaned and disinfected with bleach and 75% ethanol and 
sprayed with RNaseZap for RNase inhibition, before tissue collection and between euthanisation of animals. 
Bronchial lymph node tissues were harvested immediately and flash frozen in liquid nitrogen, placed on dry ice 
and then transferred to a −80 °C freezer for storage.
Statistical analysis of clinical and haematological data. Clinical score and haematological var-
iables (white blood cell number, neutrophil percentage, lymphocyte percentage, monocyte percentage and 
eosinophil percentage) were analysed using repeated measures mixed models (MIXED procedure of SAS v 9.4) 
where time-point defined the repeated measure. Data were first assessed for normality using PROC REG and 
PROC UNIVARIATE. All data were found to be normally distributed. Treatment (BRSV challenged or control), 
time-point or group (A, B or C) and their interactions were included as fixed effects. Calf was included as a 
random effect. A Tukey adjustment was used to correct for multiple testing. Means and their standard errors are 
presented in Figs 2 and S2 (graphs were generated in GraphPad Prism version 7.02). Lung scores were assessed 
for normality using PROC REG and PROC UNIVARIATE and analysed using a mixed model ANOVA (MIXED 
procedure of SAS v 9.4) with treatment (BRSV challenged or control) or group included as fixed effects. The pres-
ence or absence of lung lesions was analysed using a Fisher’s Exact test in SAS 9.4.
RNA extraction. Total RNA (including miRNAs) was extracted using the Qiagen RNeasy Plus Universal 
Mini Kit (Qiagen LTD, Manchester, UK), according to the manufacturer’s instructions including Appendix C of 
the manufacturer’s protocol. The quantity of the extracted RNA was determined by measuring the absorbance 
at 260 nm with a Nanodrop spectrophotometer (NanoDrop technologies; Wilmington, DE, USA). The quality of 
the extracted RNA was examined with the Agilent 2100 Bioanalyser (Agilent Technologies Ireland Ltd; Dublin, 
Ireland) using the RNA 6000 Nano LabChip kit (Agilent Technologies Ireland Ltd; Dublin, Ireland). Samples had 
a mean RNA Integrity Number of 8.6 ± 0.31.
Figure 2. Clinical scores from the BRSV challenged (n = 12) and the control (n = 6) calves during the BRSV 
challenge study (means and their standard errors are presented). The day of the challenge is represented as day 0.
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RNA-Seq library preparation and sequencing. Extracted RNA was shipped frozen at −80 °C on dry 
ice to the University of Missouri’s DNA Core Facility for RNA-Seq library preparation using the TruSeq stranded 
mRNA Kit (Illumina, San Diego, California, USA) and high-throughput sequencing (75 bp paired-end) on an 
Illumina NextSeq 500. All sequence data produced in this study has been deposited to NCBI GEO repository and 
are available through the series accession number GSE131452.
Alignment of sequence reads to the bovine reference genome and differential gene expres-
sion analysis. Adapter trimmed sequence reads in FASTQ format were assessed for quality using FastQC 
(version 0.11.7) (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). All reads passed the basic qual-
ity statistics. Reads were aligned to the UMD3.1 bovine reference genome and read counts were generated by 
converting aligned reads into counts per gene using the Spliced Transcripts Alignment to a Reference (STAR) 
aligner (version 2.5.2b)22.
Differential gene expression was determined using the R (R version 3.4.2 2017-09-28) Bioconductor package 
EdgeR (version 3.20.9)23 which accounts for biological and technical variation by modelling data as a negative 
binomial distribution. To remove lowly expressed genes, any genes with less than one count per million in at least 
three of the samples, were removed from the analysis. Data were normalised across libraries using the trimmed 
mean of M-values normalisation method24. The quantile-adjusted conditional maximum likelihood (qCML) 
common dispersion and the qCML tagwise dispersions were used to estimate dispersion. Exact tests were used 
for the detection of DEG between BRSV challenged and control calves. Genes with a Benjamini-Hochberg false 
discovery rate (FDR) of 10% and a fold change of ≥2 were considered differentially expressed.
pathway and gene ontology analysis. Statistically significant gene ontology terms, pathways and other 
gene function related terms were analysed from a ranked DEG list (DEG between BRSV challenged and control 
calves with an FDR of 10% and a fold change of >2, ranked by P-value) using g:Profiler version 2018-06-2125. 
Multiple testing correction was performed using the g:Profiler tailor-made algorithm g:SCS.
The DEG between BRSV challenged and control calves, with an FDR of 10% and a fold change of >2, were ana-
lysed for over-represented gene ontology terms/pathways and functional annotation clustering using the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov/tools.jsp)26. The 
enrichment P-values for each annotation term were derived from a modified Fisher’s exact test called the EASE 
score. The group enrichment score for each functional annotation cluster was calculated from the geometric mean 
(in the -log scale) of all the enrichment P-values in each annotation term within each cluster and was used to deter-
mine the significance of results from the functional annotation clustering analysis. A group enrichment score thresh-
old of 1.3 (EASE = 0.05) was applied.
To further examine over-represented pathways, cellular and molecular functions and predicted upstream reg-
ulators, the RNA-Seq data were analysed using the Ingenuity Pathway Analysis (IPA) (QIAGEN Inc., https://www.
qiagenbioinformatics.com/products/ingenuitypathway-analysis), according to the manufacturer’s instructions27. 
Within IPA, Fisher’s exact test was used with the Benjamini-Hochberg correction for multiple testing for the 
identification of over-represented pathways and over-represented molecular and cellular functions with a FDR 
of 10%, from DEG between BRSV challenged and control calves, with an FDR of 10% and a fold change of >2. 
Additionally, IPA’s regulation Z-score algorithm, which predicts increases or decreases in functions based on 
directional changes in the DEG and expectations derived from the literature, was used to predict differences in 
the over-represented cellular and molecular functions. IPA software considered cellular and molecular functions 
with a regulation Z-score value of ≥2.0 to be significantly increased and cellular and molecular functions with a 
regulation Z-score value of ≤−2.0 to be significantly decreased.
Comparison to the BRSV-associated RNA-Seq Data from Tizioto et al. (2015). FASTQ files were 
downloaded from the National Center for Biotechnology Information Sequence Read Archive under acces-
sion number SRP052314 (SRR1952354, SRR1952355, SRR1952356, SRR1952357, SRR1952358, SRR1952359, 
SRR1952360)18. Alignment, gene counts, differential gene expression analysis, pathway and gene ontology analy-
ses were performed identically to the analyses described for the current study. Pathway and gene ontology analy-
ses were additionally performed on genes which were commonly differentially expressed in this study and that of 
Tizioto et al.18 with an FDR of 10% and a fold change of >2.
Results
clinical score. Clinical score was affected by treatment (BRSV challenged 42.0 ± = 4.02 versus control 
27.3 ± 5.68; P = 0.03) (Fig. 2). Time-point of clinical assessment also affected clinical scores (P < 0.0001) (Fig. 2) 
with days 4 (52.7 ± 7.42) and 7 (45.2 ± 7.42) being significantly greater than day 0 (25.5 ± 7.42). There was a ten-
dency towards an interaction between time-point and treatment affecting clinical scores (P = 0.1), with the BRSV 
challenged calves having numerically greater clinical scores on day 7 versus day 2 (P < 0.1) and the control calves 
having significantly greater clinical scores on days 4 and 6 compared to day 2 (P < 0.05). However, there were no 
significant differences or tendencies between the BRSV challenged calves and the control calves at any of the time-
points (P > 0.05). Furthermore, there was no effect of group on clinical scores (P > 0.05).
Haematology variables. Control calves had greater (P <  0.0001) white blood cell counts 
(10.8 ± 0.47 × 109/L) than the BRSV challenged calves (7.5 ± 0.33 × 109/L) (Supplementary Fig. S2A). Time-point 
significantly influenced the white blood cell count (P < 0.006) which was lower on day 7 relative to day -1 
(P < 0.05) (Supplementary Fig. S2A).
There were no effects of treatment (BRSV challenged versus control), time-point or an interaction between 
treatment and time-point for either neutrophil, monocyte or lymphocyte percentage (P > 0.05). While there were 
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no effects of treatment, time-point or their interactions on eosinophil percentage (P > 0.05), there was an effect of 
group (A, B or C) (P = 0.02). BRSV challenged calves in group C had a greater percentage of eosinophils than the 
control calves in group A (P = 0.02) (BRSV challenged calves in group C; 7.3 ± 1.12%, BRSV challenged calves in 
group B; 4.3 ± 1.12%, control calves in group A; 2.3 ± 1.07%) (Supplementary Fig. S2B).
Lung pathology. Figure 3 shows the lung pathologies from a subset of the BRSV challenged calves. There 
were no differences in either the overall lung scores or the percentage of the right cranial lung lobe that was 
lesioned between the BRSV challenged calves and the controls (P > 0.05). This is likely due to the small percent-
ages of lesioned tissues present on the lungs (BRSV challenged group average percentage of lesioned tissue overall 
was 1.34 ± 1.0% and the right cranial lobe 1.63 ± 0.8%, controls 0.08 ± 0.1% and 0.83 ± 0.8%) (Table 1).
However, overall, only one control calf exhibited a lesioned lung, while 5 out of the 6 calves in BRSV challenge 
group B and 4 out of the 6 calves in BRSV challenge group C had lung lesions (Table 1). The BRSV challenged 
calves had a higher probability of having a lesioned lung compared with the control calves (P = 0.04).
Sequence alignment. An average of 53,878,694 (2 × 75 bp) paired-end reads (i.e. 26,939,347 sequenced 
fragments) were generated for each sample (Supplementary Table S2). Overall, 7.2% of the sequence reads failed 
to map to the genome and 89.6% of sequence reads mapped uniquely to the genome. On average, 57.3% of 
the total number of sequence reads were assigned to a gene by STAR, 0.4% were ambiguous and 31.9% of the 
sequence reads aligned to no feature (Supplementary Table S2).
Differential gene expression and functional annotation. Using Edge-R, a multi-dimensional scaling 
(MDS) plot was produced which allowed an examination of the similarity of the samples based on global gene 
expression when samples were plotted using their first two principal components. The MDS plot indicated no 
differences between individuals in BRSV challenge groups B and C, but a clear separation between the BRSV 
challenged and the control calves (Fig. 4).
Figure 3. Photos of the lungs illustrating the pathologies from a subset of the BRSV challenged calves. Lesions 
are marked with black arrows. (A) = calf number 8, (B) = calf number 9, (C) = calf number 16, (D) = calf 
number 17.
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There were 934 DEG (p < 0.05, FDR < 0.1, fold change >2) between the BRSV challenged and control calves 
(Supplementary Table S3). There were two DEG between the calves in BRSV challenge group B and BRSV chal-
lenge group C (PPP1R1B and LYNX1).
From the g:Profiler analysis, there were 133 over-represented biological process Gene Ontology terms, 26 
over-represented cellular component Gene Ontology terms, 23 over-represented molecular function Gene 
Ontology terms, 17 molecular function KEGG pathways and 20 over-represented Reactome pathways (Pcorrected 
<0.05) (Supplementary Table S4). The 12 most significant over-represented biological process Gene Ontology 
terms were related to the immune response (Table 2). The over-represented KEGG pathways were also associated 
with immune response and diseases and included KEGG:05164 Influenza A (Fig. 5)28. This pathway contained 19 
up-regulated and two down-regulated genes (Supplementary Table S4, Fig. 5).
There were 77 over-represented ontology terms in the DAVID analysis (p < 0.05, Benjamini-Hochberg FDR 
<0.1) (Supplementary Table S5). These were associated with the immune response, glycoproteins and secreted 
peptides. There were 28 enriched functional annotation clusters in the DAVID analysis (group enrichment score 






1 control A 0 0
2 control A 0 0
3 control A 0 0
4 control A 0.46 5
5 control A 0 0
6 control A 0 0
7 BRSV B 0 0
8 BRSV B 0.22 0
9 BRSV B 11.7 10
10 BRSV B 0.06 1
11 BRSV B 0.735 2
12 BRSV B 0.03 0.5
13 BRSV C 0.12 1
14 BRSV C 0 0
15 BRSV C 0 0
16 BRSV C 0.71 2
17 BRSV C 1.3 2
18 BRSV C 1.19 1
Table 1. Lung scores (percentage of lungs with lesioned tissue) in control and BRSV challenged calves.
Figure 4. An MDS plot generated in EdgeR illustrating the similarity of the samples based on the first two 
principal components of gene expression covariance matrix among individuals. Samples from BRSV challenged 
calves are coloured in red and samples from control calves are coloured in blue. The numbers (1–18) refer to the 
calf ID and the letter S in front of the numbers refers to the word “sample”.
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Term ID Term name P-value
GO:0006952 defense response 6.59E-17
GO:0006955 immune response 3.75E-16
GO:0002376 immune system process 4.07E-16
GO:0002252 immune effector process 4.96E-14
GO:0009605 response to external stimulus 2.68E-12
GO:0006950 response to stress 2.43E-11
GO:0009607 response to biotic stimulus 1.19E-10
GO:0098542 defense response to other organism 3.29E-10
GO:0051707 response to other organism 4.78E-10
GO:0043207 response to external biotic stimulus 6.05E-10
GO:0002377 immunoglobulin production 3.17E-09
GO:0009615 response to virus 2.99E-08
Table 2. The 12 most significant over-represented biological process Gene Ontology terms among the genes 
which were differentially expressed between BRSV challenged and control calves.
Figure 5. Genes up-regulated (red) in BRSV challenged calves (n = 12) in the KEGG:05164 Influenza A 
pathway28 (https://www.genome.jp/kegg/tool/map_pathway2.html).
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immunoglobulin, nucleotide-binding, thrombospondin, endoplasmic reticulum, double-stranded RNA binding, 
viral diseases, inflammatory responses, lectins, chemokine activity, extracellular matrix structure, cell division, 
calcium binding and the complement pathway.
Ingenuity pathway analysis showed that seventeen canonical pathways were enriched (P < 0.05, FDR 
<0.1) (Supplementary Table S7, Fig. 6). Four of these pathways were predicted to be upregulated (Interferon 
Signaling, Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses, Inhibition of Matrix 
Metalloproteases and Acute Phase Response Signaling) (Z-score >2) (Supplementary Table S7, Fig. 6).
Thirty-one enriched biological functions were predicted to be increased in BRSV challenged animals com-
pared to controls (Z-score >2) (Supplementary Table S8). Their functions were related to the recruitment, acti-
vation and death of leukocytes.
There were 256 up-stream regulators that were predicted by IPA to be activated (Z-score ≥2) (Supplementary 
Table S9). Nine of these had an observed increase in fold change (IFNG, IRF7, DDX58, CGAS, OSM, IL27, EIF2AK2, 
XBP1 and TBX21). There were 84 up-stream regulators that were predicted to be inhibited by IPA (Z-score ≤2) 
(Supplementary Table S9), but none of these were found to have a decreased expression in the BRSV challenged calves.
Differential gene expression and functional annotation of RNA-Seq data in comparison to Tizioto 
et al. (2015) study. An average of 106,159,694 paired-end reads (2 × 50 bp) (i.e. 53,079,847 sequenced fragments) 
were obtained from each BRSV challenged/control bronchial lymph node sample downloaded from the National 
Center for Biotechnology Information Sequence Read Archive under accession number SRP052314 (Supplementary 
Table S2)18. Overall, 11.7% of sequence reads failed to map to the genome and 82.7% of reads mapped uniquely to the 
genome, using the STAR aligner22. On average, 28.0% of the total number of sequence reads were assigned to a gene by 
STAR, 0.1% were ambiguous and 54.6% of reads aligned to no feature (Supplementary Table S2).
An MDS plot illustrating the similarity of the Tizioto et al.18 BRSV challenged and control bronchial lymph 
node samples based on log2 fold gene expression changes was produced in EdgeR (Fig. 7). For illustration of the 
similarities between the samples in the present study and those from the Tizioto et al.18 study, an MDS plot was 
produced in EdgeR based on log2 fold gene expression changes among all samples (Fig. 8).
One thousand and thirteen genes from the study of Tizioto et al.18 were differentially expressed between 
BRSV challenged and control calves (Supplementary Table S10). From the g:Profiler analysis, there were 198 
over-represented biological process Gene Ontology terms, 19 over-represented cellular component Gene 
Ontology terms, 16 over-represented molecular function Gene Ontology terms, 18 over-represented KEGG 
pathways, 38 over-represented Human Phenotype Ontology terms, 1 over-represented CORUM term and 30 
over-represented Reactome pathways (Pcorrected <0.05) (Supplementary Table S11). The over-represented bio-
logical process Gene Ontology terms were related to the immune response. The over-represented KEGG path-
ways were also associated with immune responses and diseases and included KEGG:05164 Influenza A and 
KEGG:04060 Cytokine-cytokine receptor interaction.
There were 354 DEG in common between the present study and the Tizioto et al.18 study (BRSV challenged 
and control bronchial lymph node samples) (Supplementary Table S12). From the g:Profiler analysis, there were 
81 over-represented biological process Gene Ontology terms, 18 over-represented cellular component Gene 
Ontology terms, 13 over-represented molecular function Gene Ontology terms, 16 over-represented KEGG 
pathways, 12 over-represented Human Phenotype Ontology terms, 1 over-represented CORUM term and 20 
over-represented Reactome pathways (Pcorrected <0.05) among the DEG in common between the two data sets 
(Supplementary Table S13).
Figure 6. The enriched canonical pathways found in the IPA analysis27 (P < 0.05, FDR <0.1). The pathways 
are shown on the x-axis and the –Log Benjamini-Hochberg adjusted p values are displayed on the y-axis. The 
threshold is set to 1 which equals a Benjamini-Hochberg adjusted p value of 0.1. The orange line representing 
the ratio corresponds to the ratio of the number of differentially expressed genes that map to the pathway 
divided by the total number of genes that map to the same pathway. Pathways with a positive z-score are 
predicted by IPA to have increased activity and pathways with a negative z-score are predicted to have decreased 
activity.
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Pathway analysis in IPA revealed that 15 pathways were over-represented among the DEG in common 
between the present study and the Tizioto et al.18 study (Fig. 9, Supplementary Table S14). The most significant of 
the over-represented pathways, interferon signaling and the role of pattern recognition receptors in recognition of 
bacteria and viruses, were also among the most significant over-represented pathways in the IPA pathway analysis 
of the DEG solely found in this study.
Fourteen enriched biological functions, among DEG in common between the present study and the Tizioto 
et al.18 study, were predicted to be increased in BRSV challenged animals compared to controls (Z-score >2) 
(Supplementary Table S15). Functions were related to the antimicrobial and antiviral immune response. Twelve 
enriched biological functions, among DEG in common between the present study and the Tizioto et al.18 study, 
were predicted to be decreased in BRSV challenged animals compared to controls (Z-score >2) (Supplementary 
Table S15). These functions were associated with viral replication and morbidity.
Discussion
This is the first study to examine the host response at the transcriptional level in artificially-reared 
Holstein-Friesian calves to a challenge with BRSV. Previous studies have examined the bronchial lymph node 
pathological response to a BRSV challenge in Angus-Hereford crossbred beef calves18,19,21. However, immune 
responses, particularly at the level of transcription, have been demonstrated to be affected by breed29–31. This 
Figure 7. An MDS plot generated in EdgeR illustrating the similarity of the Tizioto et al.18 BRSV challenged 
(n = 4) and control (n = 3) bronchial lymph node samples based on log2 fold gene expression changes. Samples 
from BRSV challenged calves are coloured in red and samples from control calves are coloured in blue. The 
sample names are the accession numbers of the samples.
Figure 8. An MDS plot (based on log2 fold gene expression changes) generated in EdgeR illustrating the 
similarity between the BRSV challenged (n = 12) and control (n = 6) bronchial lymph node samples from the 
present study and from the Tizioto et al.18 study.
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may be the reason that the majority of the variation observed in the MDS plot (Fig. 8) was due to study (the pres-
ent study versus Tizioto et al.18), while treatment (BRSV challenged versus control) bronchial lymph node gene 
expression was the secondary source of variation. However, the different sequencing platforms used (NextSeq 500 
versus HiSeq 2000), the varying length and depth of reads generated, the distinct BRSV viral strains used in the 
inoculum and the alternative husbandry and management practices carried out in the studies’ diverse geograph-
ical locations, may have also influenced the alterations in gene expression between the two studies. Despite the 
many sources of variation existing between the two studies, 38% of the DEG in this study were commonly differ-
entially expressed in the RNA-Seq analysis of the BRSV challenged and control bronchial lymph node samples 
from the study of Tizioto et al.18. Furthermore, the majority of enriched pathways found in the two studies were 
in common. Therefore, BRSV appears to elicit many conserved alterations in gene expression.
In the present study, calves were challenged with a similar titre of BRSV that has consistently and successfully 
been used to establish infection in previous BRSV challenge studies18,21,32. Calves were euthanised 7 days post chal-
lenge as this is the time-point when the acute phase response has been observed to peak33 and when live BRSV 
and its antigen titres begin to decrease34. Bronchial lymph node tissues were harvested and RNA-Seq analysis was 
performed on these tissues to determine the gene expression changes induced by BRSV infection as these lymph 
nodes drain the lungs and are the site of antigen presentation and the initiation of the primary immune response35,36.
Infection with BRSV can be subclinical, present only in the upper respiratory tract or it can affect both the 
upper and lower parts of the respiratory tract15. BRSV mainly infects and produces clinical signs in calves less 
than one year of age but is usually more severe in young calves aged between one and three months32. It is com-
mon for paramyxoviruses, including BRSV, to be attenuated by passage through in vitro culture, and this can 
result in minimal clinical symptoms of respiratory disease37. Therefore, the age of the calves (approximately 5 
months of age) and the effects of BRSV attenuation in culture may have influenced the primarily sub-clinical 
response to BRSV challenge observed in the present study. The calves in this study had substantially lower clinical 
scores than the calves challenged with BRSV in the Tizioto et al.18,21 study. This may have been due to the possible 
differing initial BRSV specific MDA levels of the calves, the diverse breeds of the calves or the distinct strains of 
BRSV inoculum used for the challenge. Furthermore, there were no changes in neutrophil, lymphocyte or mono-
cyte percentages due to the BRSV challenge in this study. While control calves did have a higher white blood cell 
count compared with BRSV challenged calves throughout the study, the white blood cell numbers were within 
the normal range for healthy cattle38 and no increase in white blood cell count was observed following virus inoc-
ulation, in BRSV challenged calves.
Interestingly, despite these BRSV challenged calves only showing a modest clinical and haematological 
response to infection, and having only a small proportion of their lungs lesioned, the virus induced vast changes 
in bronchial lymph node gene expression levels. Therefore, measuring host gene expression levels may prove to 
be a more accurate way of diagnosing BRD than by the observation of clinical signs of the disease. This would be 
hugely beneficial to the global agricultural industry as sub-clinical BRD which remains undiagnosed is almost as 
prevalent in healthy cattle as BRD is among cattle which are diagnosed with respiratory disease and treated for 
BRD39. Although it would clearly not be possible to measure host gene expression in bronchial lymph node tissue 
in live calves if a small set of diagnostic genes are also perturbed in expression in white blood cells or nasal fluid, 
these more accessible media could be used as “liquid biopsies” for the future diagnosis of subclinical respiratory 
infections. Indeed increased expression of IFNG and IL6 have been observed along with clinical signs during an 
Figure 9. The enriched canonical pathways in the IPA analysis27 among DEG in common between the present 
study and the Tizioto et al.18 study (P < 0.05, FDR <0.1). The pathways are shown on the x-axis and the –Log 
Benjamini-Hochberg adjusted p values are displayed on the y-axis. The threshold is set to 1 which equals a 
Benjamini-Hochberg adjusted p value of 0.1. The orange line representing the ratio corresponds to the ratio of 
the number of differentially expressed genes that map to the pathway divided by the total number of genes that 
map to the same pathway. Pathways with a positive z-score are predicted by IPA to have increased activity and 
pathways with a negative z-score are predicted to have decreased activity.
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initial BRSV challenge and the increased expression of IFNG in the peripheral blood mononuclear cells of young 
calves with an absence of clinical symptoms has also been observed in a reinfection with BRSV34.
The majority of the alterations in bronchial lymph node gene expression due to BRSV challenge detected in the 
present study were associated with the immune response. The most highly upregulated gene was GZMB, which 
was upregulated sixty-seven fold. This gene was also the most up-regulated in response to a BRSV challenge in 
bronchial lymph node in US calves18 and the encoded protein has been shown to be significantly increased in 
CD8+ and CD4+ T cells and natural killer cells, in tracheal aspirates from children infected with respiratory 
syncytial virus (RSV)40. Furthermore, GZMB was found to be a member of several enriched ontologies and path-
ways including “defense response”, “immune response”, “granzyme-mediated apoptotic signaling pathway” and 
“granzyme B signaling”, in the present study. The serine protease protein encoded by this gene is one of the major 
components of the lytic granules which are released by cytotoxic T cells and natural killer cells to destroy virally 
infected cells41. It also plays a role in degradation of the extracellular matrix and induction of pro-inflammatory 
cytokine responses42. Furthermore, granzyme B has recently been found to be utilised by T regulatory cells to 
control effector B and T cell populations, thereby regulating the inflammatory response and reducing the severity 
of RSV disease in mice43. Consequently, it is likely to play an important role in defence to BRSV infection and 
alterations to this gene may be critically important to BRD resistance and susceptibility. Indeed, it has been shown 
that polymorphisms in murine GZMB can reduce the ability of CD8+ T cells to kill virally infected target cells44. 
It has also been postulated that that GZMB-expressing T regulatory cells could be used as a therapeutic strategy in 
human viral lung infections, due to their ability to dampen inflammation without elevating viral load43. However, 
a study of mice experimentally infected with Klebsiella pneumoniae found that while GZMB knockout mice had 
higher levels of lung inflammation at earlier stages in the disease, there were minimal differences in distant organ 
injury or survival between the knockout and wild type mice45. However, Klebsiella pneumoniae is caused by a 
bacterium rather than a virus and as GZMB is mainly involved in the cell mediated cytotoxic immune response, 
it may be more effective in the elimination of viral infections and intracellular bacteria.
Pathways and gene ontologies involved in the innate immune response, induction of cytokines and chemokines, 
humoral and cell mediated immunity were over-represented among the DEG. The KEGG pathway for Influenza A 
was enriched for DEG and this pathway contains upregulated cytokines responsible for the induction of the febrile 
response, mitochondrial genes involved in programmed cell death and interferon stimulated genes which induce 
cytotoxic T cell responses. Tizioto et al.18 also observed an enrichment of similar pathways and the DEG found 
in common in both studies were members of the most significantly enriched pathways from this study, including 
interferon signaling and role of pattern recognition receptors in recognition of bacteria and viruses. Furthermore, 
the induction of pro-inflammatory chemokines and cytokines in calves due to BRSV infection has been reported in 
pneumonic lung lesions46, bronchoalveolar lung fluid47 and bovine respiratory/turbinate epithelial cells48. Therefore, 
these immune response associated genes seem to play an important role in the bovine host response to BRSV infec-
tion. This is expected as pathogen recognition, induction of inflammatory cytokines and chemokines, and the 
initiation of the innate immune response are vital to control the virus upon entry. Subsequent elimination of the 
virus requires the development of CD8 cytotoxic T cells, which is facilitated by the production of IFNG and inter-
feron stimulated genes such as DDX58, IFI44, IFIH1, IFIT1, IFIT2, IFIT3, IFIT5, ISG15, ISG20, MX1, MX2, OAS1, 
EIF2AK2, RTP4, RSAD2, OAS2 and OSM, which were upregulated in the present study49.
In agreement with Tizioto et al.18, we also predicted neurodegenerative diseases and functions including “pro-
gressive motor neuropathy”, “progressive neurological disorder”, “inflammatory demyelinating disease” and “mul-
tiple sclerosis” to be increased in the BRSV challenged calves. These findings are interesting as human RSV has 
been observed as being capable of infecting murine lung neuronal cells50, and also of infecting the human central 
nervous system and inducing neurological symptoms51.
BRSV modulates the immune response towards a T helper 2 (Th2) type response, with increased expression of 
Th2 promoting cytokines and increased concentrations of BRSV specific IgE antibodies in lymph fluid48. Despite 
enriched ontology terms including “B cell activation” and “immunoglobulin mediated immune response”, we 
found no evidence for an increase in the transcription of either IL4 or IL13 which initiate the Th2 bias52. This is 
consistent with the results of Grell et al.34, who did not detect an increase in IL4 gene expression following a BRSV 
challenge. However, although there was a 2 fold increase in the expression of IL12RB2, a transmembrane protein 
subunit of the interleukin 12 receptor complex, there was no increase in the expression of IL12, which is necessary 
to induce Th1 cell proliferation responses48, which is consistent with the expected Th2 bias for BRSV.
Lipopolysaccharide (LPS) was a predicted upstream regulator in this study and that of Tizioto et al.18. 
Furthermore, LBP was the second greatest up-regulated gene in response to the BRSV challenge infection in this 
study (fold change = 52). This is likely because the fusion protein from BRSV interacts with TLR4 to initiate the 
innate immune response in a manner that is similar to LPS48. Tizioto et al.18 suggested that LPS has the potential 
to be used in new treatments aiming to prevent the occurrence of BRD as it induces a cascade of both anti-viral 
and anti-bacterial genes. Other predicted upstream regulators in the present study include IFNG and IRF7, which 
play roles in IFN antiviral innate immune responses53.
BRSV is closely related to human RSV, and induces similar pathologies15,37 and alterations in host gene expres-
sion. Genes involved in the type 1 interferon antiviral response, including BP1, RSAD2, MX2, MX1, ISG15, IRF7, 
IFITM3, IFIT3, IFIT2, IFIT1, IFIH1, IFI44, which were upregulated in the lungs of C57BL/6 mice, in response to 
infection with RSV54, were also up-regulated in the calves challenged with BRSV in the present study. Therefore, the 
gene expression changes induced by BRSV infection detected in this study may provide an insight into the human 
bronchial lymph node transcriptional response to RSV. Future studies will also elucidate the bovine host micro-RNA 
gene expression responses and determine the regulatory regions controlling these transcriptional alterations due to 
infection with BRSV, in bronchial lymph node, and in other important respiratory tissues including lesioned and 
healthy lung tissue, mediastinal and retropharyngeal lymph nodes, and the pharyngeal tonsil. The DEG identified 
in this study, particularly those also observed to be DEG in the study of Tizioto et al.18, and therefore involved in 
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the bovine host response to BRSV infection along with the regulatory regions controlling transcriptional changes in 
these genes may be interrogated in future large scale studies for the identification of variants which may be associ-
ated with resistance to BRSV infection. These variants could be included on genotyping assays routinely used in the 
international beef and dairy cattle industries for use in breeding programmes targeted on the generation of healthier, 
more robust cattle with a greater potential to resist BRSV infection and subsequent BRD.
Data Availability
All sequence data produced in this study has been deposited to NCBI GEO repository and are available through 
series Accession Number GSE131452.
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